04/20/2026
GLP-1 drugs are everywhere right now. But the conversation is shifting ⚠️
As demand grows, so do concerns around safety, sourcing, and long term use. From digital hype to unregulated alternatives, GLP-1 drug risks are becoming a critical part of the wellness conversation.
Our blog “GLP-1 Drug Risks, Digital Demand, and Emerging Wellness Trends” explores how social platforms, expanded access, and limited oversight are reshaping health decisions.
✨ Understanding risk is just as important as access.
🔗 Read the post https://medikeeper.com/blog/glp-1-drug-risks/